Thursday, July 5, 2012

Intravenous Immune Globulin (IVIG)


With IVIG, a patient receives high dose immune globulin intravenously. Immune globulin is a human blood product pooled from multiple donors who are carefully screened. By providing the body with normal antibodies from donated blood, IVIG treatments appear to temporarily modify the immune system. For most individuals, MG weakness typically improves within a week of treatment and lasts for several weeks or months. IVIG treatments are very expensive and offer short-term relief from MG symptoms.
Side effects—for instance, headache or allergic symptoms--are usually related to how fast the drug is administered.

No comments:

Post a Comment